Tale Of Two ALS Drugs: Similar Study Design, Different Take By US FDA

 
• By Brenda Sandburg
Path fork
US FDA takes different paths in review of two ALS drugs • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers